Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Thiazolidinediones Tied to Lower Cancer Risk in Diabetes Patients
Pioglitazone, rosiglitazone linked to lower liver cancer risk; rosiglitazone tied to lower CRC risk
This article is older than one year and is no longer available.

Copyright © 2012 HealthDay. All rights reserved.

August 21, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

FDA Approves Cerdelga for Type 1 Gaucher Disease

Organized Processes Help Practices Hire Well

Pistachio-Supplemented Diet Beneficial in Prediabetes

Docs Must Consider Liability When Ordering Screening Tests

Factors Identified for Reconstruction Post-Mastectomy

Active Surveillance Works Well for Stage I Testicular Cancer